229 related articles for article (PubMed ID: 30333538)
21. Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU.
Chaparro M; Garre A; Ricart E; Iglesias-Flores E; Taxonera C; Domènech E; Gisbert JP;
Aliment Pharmacol Ther; 2019 Feb; 49(4):419-428. PubMed ID: 30637837
[TBL] [Abstract][Full Text] [Related]
22. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease.
Söderlund S; Brandt L; Lapidus A; Karlén P; Broström O; Löfberg R; Ekbom A; Askling J
Gastroenterology; 2009 May; 136(5):1561-7; quiz 1818-9. PubMed ID: 19422077
[TBL] [Abstract][Full Text] [Related]
23. Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
Hyams JS; Dubinsky MC; Baldassano RN; Colletti RB; Cucchiara S; Escher J; Faubion W; Fell J; Gold BD; Griffiths A; Koletzko S; Kugathasan S; Markowitz J; Ruemmele FM; Veereman G; Winter H; Masel N; Shin CR; Tang KL; Thayu M
Gastroenterology; 2017 Jun; 152(8):1901-1914.e3. PubMed ID: 28193515
[TBL] [Abstract][Full Text] [Related]
24. Incidence and risk factors for lymphoma in a single-center inflammatory bowel disease population.
Chiorean MV; Pokhrel B; Adabala J; Helper DJ; Johnson CS; Juliar B
Dig Dis Sci; 2011 May; 56(5):1489-95. PubMed ID: 20953706
[TBL] [Abstract][Full Text] [Related]
25. Cancer risk in patients with inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Kliewer E; Wajda A
Cancer; 2001 Feb; 91(4):854-62. PubMed ID: 11241255
[TBL] [Abstract][Full Text] [Related]
26. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study.
Rungoe C; Simonsen J; Riis L; Frisch M; Langholz E; Jess T
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):693-700.e1. PubMed ID: 25086189
[TBL] [Abstract][Full Text] [Related]
28. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
[TBL] [Abstract][Full Text] [Related]
29. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
[TBL] [Abstract][Full Text] [Related]
31. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
Beaugerie L; Svrcek M; Seksik P; Bouvier AM; Simon T; Allez M; Brixi H; Gornet JM; Altwegg R; Beau P; Duclos B; Bourreille A; Faivre J; Peyrin-Biroulet L; Fléjou JF; Carrat F;
Gastroenterology; 2013 Jul; 145(1):166-175.e8. PubMed ID: 23541909
[TBL] [Abstract][Full Text] [Related]
32. Increased Risk of Oral Cancer in Patients With Inflammatory Bowel Diseases.
Katsanos KH; Roda G; McBride RB; Cohen B; Colombel JF
Clin Gastroenterol Hepatol; 2016 Mar; 14(3):413-20. PubMed ID: 26499929
[TBL] [Abstract][Full Text] [Related]
33. Effect of Medications on Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Population-Based Cohort Study from Olmsted County, Minnesota.
Yadav S; Singh S; Harmsen WS; Edakkanambeth Varayil J; Tremaine WJ; Loftus EV
Mayo Clin Proc; 2015 Jun; 90(6):738-46. PubMed ID: 25963756
[TBL] [Abstract][Full Text] [Related]
34. Incidence of Infections and Malignancy Among Elderly Male Patients with IBD Exposed to Vedolizumab, Prednisone, and 5-ASA Medications: A Nationwide Retrospective Cohort Study.
Khan N; Pernes T; Weiss A; Trivedi C; Patel M; Xie D; Yang YX
Adv Ther; 2021 May; 38(5):2586-2598. PubMed ID: 33844132
[TBL] [Abstract][Full Text] [Related]
35. Risk factors of colorectal cancer in inflammatory bowel disease.
Bansal P; Sonnenberg A
Am J Gastroenterol; 1996 Jan; 91(1):44-8. PubMed ID: 8561142
[TBL] [Abstract][Full Text] [Related]
36. Risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease: a nationwide population-based study in South Korea.
Hong SN; Kim HJ; Kim KH; Han SJ; Ahn IM; Ahn HS
Aliment Pharmacol Ther; 2017 Jan; 45(2):253-263. PubMed ID: 27933686
[TBL] [Abstract][Full Text] [Related]
37. Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study.
Clowry J; Sheridan J; Healy R; Deady S; Keegan D; Byrne K; Cullen G; Mulcahy H; Comber H; Parnell AC; Doherty G; Lally A
J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):978-985. PubMed ID: 28045204
[TBL] [Abstract][Full Text] [Related]
38. Malignancy and mortality in paediatric-onset inflammatory bowel disease: a 3-year prospective, multinational study from the paediatric IBD Porto group of ESPGHAN.
Joosse ME; Aardoom MA; Kemos P; Turner D; Wilson DC; Koletzko S; Martin-de-Carpi J; Fagerberg UL; Spray C; Tzivinikos C; Sladek M; Shaoul R; Roma-Giannikou E; Bronsky J; Serban DE; Ruemmele FM; Garnier-Lengline H; Veres G; Hojsak I; Kolho KL; Davies IH; Aloi M; Lionetti P; Hussey S; Veereman G; Braegger CP; Trindade E; Wewer AV; Hauer AC; de Vries ACH; Sigall Boneh R; Sarbagili Shabat C; Levine A; de Ridder L;
Aliment Pharmacol Ther; 2018 Sep; 48(5):523-537. PubMed ID: 29984520
[TBL] [Abstract][Full Text] [Related]
39. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome.
García Rodríguez LA; Ruigómez A; Wallander MA; Johansson S; Olbe L
Scand J Gastroenterol; 2000 Mar; 35(3):306-11. PubMed ID: 10766326
[TBL] [Abstract][Full Text] [Related]
40. Malignancies in patients with inflammatory bowel disease: a nationwide register study in Finland.
Jussila A; Virta LJ; Pukkala E; Färkkilä MA
Scand J Gastroenterol; 2013 Dec; 48(12):1405-13. PubMed ID: 24131389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
